AAREY DRUGS & PHARMACEUTICALS Financial Statement Analysis
|
||
|
The Revenues of AAREY DRUGS & PHARMACEUTICALS have decreased by -0.35% YoY .
The Earnings Per Share (EPS) of AAREY DRUGS & PHARMACEUTICALS has decreased by -1.42 % YoY. |
||
AAREY DRUGS & PHARMACEUTICALS Last 5 Annual Financial Results
[BOM: 524412|NSE : AAREYDRUGS]
| Standalone | Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 |
|---|---|---|---|---|---|
| Revenues | ₹472 Cr | ₹474 Cr | ₹398 Cr | ₹419 Cr | ₹493 Cr |
| Expenses | ₹465 Cr | ₹471 Cr | ₹391 Cr | ₹411 Cr | ₹481 Cr |
| Operating Profit (Excl OI) | ₹7.17 Cr | ₹2.90 Cr | ₹6.48 Cr | ₹7.72 Cr | ₹11 Cr |
| Other Income | ₹6.10 Cr | ₹9.81 Cr | ₹4.94 Cr | ₹2.73 Cr | ₹2.67 Cr |
| Interest | ₹5.00 Cr | ₹4.66 Cr | ₹4.38 Cr | ₹2.87 Cr | ₹2.04 Cr |
| Depreciation | ₹2.85 Cr | ₹1.95 Cr | ₹1.70 Cr | ₹1.57 Cr | ₹1.99 Cr |
| Profit Before Tax | ₹5.41 Cr | ₹6.10 Cr | ₹5.34 Cr | ₹6.01 Cr | ₹10 Cr |
| Profit After Tax | ₹3.97 Cr | ₹4.02 Cr | ₹4.68 Cr | ₹3.77 Cr | ₹6.56 Cr |
| Earnings Per Share (Rs) | ₹1.39 | ₹1.41 | ₹1.67 | ₹1.49 | ₹2.58 |
| PAT Margin (%) | 0.84 | 0.85 | 1.18 | 0.90 | 1.33 |
| ROE(%) | 2.81 | 3.02 | 3.82 | 3.33 | 6.31 |
| ROCE(%) | 5.57 | 6.38 | 6.09 | 6.28 | 9.87 |
| Total Debt/Equity(x) | 0.34 | 0.26 | 0.24 | 0.33 | 0.13 |
Key Financials |
||
| Market Cap | : | ₹ 349.9 Cr |
| Revenue (TTM) | : | ₹ 414.7 Cr |
| Net Profit(TTM) | : | ₹ 4.2 Cr |
| EPS (TTM) | : | ₹ 1.3 |
| P/E (TTM) | : | 83.8 |
| Industry Peers & Returns | 1W | 1M | 1Y |
| AAREY DRUGS & PHARMACEUTICALS | 1.2% | 7.5% | 31.9% |
| ADANI ENTERPRISES | -5.9% | -15% | 5.6% |
| PREMIER ENERGIES | -5% | -5.2% | -16.9% |
| ADITYA INFOTECH | -5% | 11.9% | 174.6% |
| AEGIS LOGISTICS | -7.5% | -12.3% | 63% |
| REDINGTON | -6.4% | -6.4% | 30.5% |
| RRP SEMICONDUCTOR | -3.9% | -19% | 4545.9% |
| HONASA CONSUMER | -1.3% | -6.6% | 54.7% |
| LLOYDS ENTERPRISES | -9.6% | -9.6% | -3.8% |
AAREY DRUGS & PHARMACEUTICALS Revenues
[BOM: 524412|NSE : AAREYDRUGS]
| Y-o-Y | -0.35 % |
| 5 Yr CAGR | -1.06 % |
| Years | Revenues | % Change | |
|---|---|---|---|
| Mar2026 | ₹472 Cr | -0.35 | |
| Mar2025 | ₹474 Cr | 19.19 | |
| Mar2024 | ₹398 Cr | -5.09 | |
| Mar2023 | ₹419 Cr | -14.98 | |
| Mar2022 | ₹493 Cr | - | |
AAREY DRUGS & PHARMACEUTICALS Operating Profit
[BOM: 524412|NSE : AAREYDRUGS]
| Y-o-Y | 147.41 % |
| 5 Yr CAGR | -10.94 % |
| Years | Operating Profit | % Change | |
|---|---|---|---|
| Mar2026 | ₹7.17 Cr | 147.41 | |
| Mar2025 | ₹2.90 Cr | -55.28 | |
| Mar2024 | ₹6.48 Cr | -16.06 | |
| Mar2023 | ₹7.72 Cr | -32.25 | |
| Mar2022 | ₹11 Cr | - | |
| Operating Margins | |
|---|---|
| Y-o-Y | 149.18 % |
| 5 Yr CAGR | -9.93 % |
| Years | Operating Margin% | % Change | |
|---|---|---|---|
| Mar2026 | 1.52% | 149.18 | |
| Mar2025 | 0.61% | -62.58 | |
| Mar2024 | 1.63% | -11.41 | |
| Mar2023 | 1.84% | -20.35 | |
| Mar2022 | 2.31% | - | |
AAREY DRUGS & PHARMACEUTICALS Profit After Tax
[BOM: 524412|NSE : AAREYDRUGS]
| Y-o-Y | -1.39 % |
| 5 Yr CAGR | -11.79 % |
| Years | Profit After Tax | % Change | |
|---|---|---|---|
| Mar2026 | ₹3.97 Cr | -1.39 | |
| Mar2025 | ₹4.02 Cr | -14.09 | |
| Mar2024 | ₹4.68 Cr | 24.21 | |
| Mar2023 | ₹3.77 Cr | -42.47 | |
| Mar2022 | ₹6.56 Cr | - | |
| PAT Margins | |
|---|---|
| Y-o-Y | -1.18 % |
| 5 Yr CAGR | -10.85 % |
| Years | PAT Margin(%) | % Change | |
|---|---|---|---|
| Mar2026 | 0.84 % | -1.18 | |
| Mar2025 | 0.85 % | -27.97 | |
| Mar2024 | 1.18 % | 31.11 | |
| Mar2023 | 0.9 % | -32.33 | |
| Mar2022 | 1.33 % | - | |
AAREY DRUGS & PHARMACEUTICALS Earnings Per Share (EPS)
[BOM: 524412|NSE : AAREYDRUGS]
| Y-o-Y | -1.42 % |
| 5 Yr CAGR | -14.33 % |
| Years | EPS | % Change | |
|---|---|---|---|
| Mar2026 | ₹1.39 | -1.42 | |
| Mar2025 | ₹1.41 | -15.57 | |
| Mar2024 | ₹1.67 | 12.08 | |
| Mar2023 | ₹1.49 | -42.25 | |
| Mar2022 | ₹2.58 | - | |
AAREY DRUGS & PHARMACEUTICALS Return on Capital Employed (ROCE)
[BOM: 524412|NSE : AAREYDRUGS]
| Y-o-Y | -12.70 % |
| 5 Yr CAGR | -13.33 % |
| Years | ROCE | % Change | |
|---|---|---|---|
| Mar2026 | 5.57% | -12.70 | |
| Mar2025 | 6.38% | 4.76 | |
| Mar2024 | 6.09% | -3.03 | |
| Mar2023 | 6.28% | -36.37 | |
| Mar2022 | 9.87% | - | |
AAREY DRUGS & PHARMACEUTICALS Share Price vs Sensex
| Current Share Price | : | ₹109.7 |
| Current MarketCap | : | ₹ 349.9 Cr |
| Updated EOD on | : | Oct 22,2026 |
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| AAREY DRUGS & PHARMACEUTICALS | 1.2% |
7.5% |
31.9% |
| SENSEX | 0.6% |
-1.4% |
-10.7% |
AAREY DRUGS & PHARMACEUTICALS related INDICES
You may also like the below Video Courses
FAQ about AAREY DRUGS & PHARMACEUTICALS Financials
How the annual revenues of AAREY DRUGS & PHARMACEUTICALS have changed ?
The Revenues of AAREY DRUGS & PHARMACEUTICALS have decreased by -0.35% YoY .
How the Earnings per Share (EPS) of AAREY DRUGS & PHARMACEUTICALS have changed?
The Earnings Per Share (EPS) of AAREY DRUGS & PHARMACEUTICALS has decreased by -1.42 % YoY .
|
Intrinsic Value of ADANI ENTERPRISES LTD Intrinsic Value of PREMIER ENERGIES LTD Intrinsic Value of ADITYA INFOTECH LTD Intrinsic Value of AEGIS LOGISTICS LTD Intrinsic Value of REDINGTON LTD |
ADANI ENTERPRISES LTD vs PREMIER ENERGIES LTD vs ADITYA INFOTECH LTD
AEGIS LOGISTICS LTD vs REDINGTON LTD vs